PMV Pharmaceuticals Ownership | Who Owns PMV Pharmaceuticals?


OverviewForecastFinancialsChart

PMV Pharmaceuticals Ownership Summary


PMV Pharmaceuticals is owned by 23.53% institutional investors, 2.30% insiders, and 74.17% retail investors. Orbimed advisors is the largest institutional shareholder, holding 12.56% of PMVP shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 2.95% of its assets in PMV Pharmaceuticals shares.

PMVP Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockPMV Pharmaceuticals23.53%2.30%74.17%
SectorHealthcare Stocks 57.43%9.41%33.16%
IndustryBiotech Stocks 69.02%8.92%22.06%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Orbimed advisors6.48M12.56%$9.78M
Sio capital management3.57M6.93%$5.39M
Arrowmark colorado3.51M6.80%$5.30M
Bml capital management3.47M6.72%$5.23M
Euclidean capital2.63M5.09%$3.97M
Alkeon capital management2.34M4.54%$3.54M
Vanguard group2.14M4.16%$3.24M
Pfm health sciences, lp2.08M4.03%$3.14M
Acadian asset management2.08M4.03%$3.14M
Blackrock1.16M2.26%$1.88M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Bml capital management3.47M3.25%$5.23M
Sio capital management3.57M1.52%$5.39M
Aldebaran capital502.19K0.72%$758.31K
Stonepine capital management535.80K0.65%$809.07K
Euclidean capital2.63M0.54%$3.97M
Orbimed advisors6.48M0.20%$9.78M
Pfm health sciences, lp2.08M0.19%$3.14M
Arrowmark colorado3.51M0.07%$5.30M
Velan capital investment management lp35.00K0.05%$52.85K
Shay capital156.45K0.04%$236.24K

Top Buyers

HolderShares% AssetsChange
Bml capital management3.47M3.25%1.78M
Stonepine capital management535.80K0.65%535.80K
Sio capital management3.57M1.52%357.93K
Prelude capital management134.70K0.02%103.60K
Ubs group275.46K0.00%96.60K

Top Sellers

HolderShares% AssetsChange
Blackrock1.16M--1.95M
Bank of america corp /de/340.39K--1.03M
State street145.08K--640.91K
Ecor1 capital---566.88K
Personal cfo solutions---550.34K

New Positions

HolderShares% AssetsChangeValue
Stonepine capital management535.80K0.65%535.80K$809.07K
Velan capital investment management lp35.00K0.05%35.00K$52.85K
Russell investments group4.71K-4.71K$7.63K
Macquarie group2.08K-2.08K$3.37K
Bnp paribas arbitrage, snc763.00-763.00$1.15K

Sold Out

HolderChange
Nelson, van denburg & campbell wealth management group-8.00
Avion wealth-299.00
Capital advisors-322.00
New york state common retirement fund-341.00
Private wealth management group-676.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Dec 31, 202423-69.33%12,134,994-68.90%230.41%7-75.00%8-72.41%
Sep 30, 202475-19.35%39,023,924-3.62%751.22%29-35.56%29-6.45%
Jun 30, 202493-7.00%40,490,486-5.27%781.14%45-10.00%3119.23%
Mar 31, 2024100-2.91%42,741,191-8.02%830.93%50-13.79%26-13.33%
Dec 31, 2023103-8.04%46,466,060-14.33%940.68%5818.37%30-11.76%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
Vanguard Total Stock Mkt Idx Inv1.52M2.95%-
ArrowMark Small Cap Gro1.26M2.43%-
Meridian Small Cap Growth Legacy1.26M2.43%-
Vanguard Institutional Extnd Mkt Idx Tr540.35K1.04%-
SQUAD Aguja Opportunities I450.00K0.87%-
BlackRock Advantage Small Cap Core Instl280.44K0.54%-
Goldman Sachs Small Cp Val Insghts Instl249.01K0.48%-
Fidelity Extended Market Index220.95K0.43%-10.14K
Vanguard Health Care ETF140.02K0.27%2.32K
Bridgeway Ultra-Small Company Market124.40K0.24%-15.50K

Recent Insider Transactions


DateNameRoleActivityValue
Sep 11, 2024Jalota Deepika Chief Development OfficerSell$10.85K
Sep 11, 2024Carulli Michael Chief Financial OfficerSell$4.35K
Nov 22, 2023ORBIMED ADVISORS LLC-Sell$195.76K
Sep 15, 2023Jalota Deepika Chief Development OfficerSell$27.17K
Sep 15, 2023Alland Leila Chief Medical OfficerSell$41.65K

Insider Transactions Trends


DateBuySell
2025 Q1--
2024 Q4--
2024 Q3-2
2024 Q2--
2024 Q1--

PMVP Ownership FAQ


Who Owns PMV Pharmaceuticals?

PMV Pharmaceuticals shareholders are primarily institutional investors at 23.53%, followed by 2.30% insiders and 74.17% retail investors. The average institutional ownership in PMV Pharmaceuticals's industry, Biotech Stocks , is 69.02%, which PMV Pharmaceuticals falls below.

Who owns the most shares of PMV Pharmaceuticals?

PMV Pharmaceuticals’s largest shareholders are Orbimed advisors (6.48M shares, 12.56%), Sio capital management (3.57M shares, 6.93%), and Arrowmark colorado (3.51M shares, 6.80%). Together, they hold 26.28% of PMV Pharmaceuticals’s total shares outstanding.

Does Blackrock own PMV Pharmaceuticals?

Yes, BlackRock owns 2.26% of PMV Pharmaceuticals, totaling 1.16M shares as of Jun 2024. This represents 0% of BlackRock's total assets, with a market value of 1.88M$. In the last quarter, BlackRock decreased its holdings by -1.948M shares, a -62.63% change.

Who is PMV Pharmaceuticals’s biggest shareholder by percentage of total assets invested?

Bml capital management is PMV Pharmaceuticals’s biggest shareholder by percentage of total assets invested, with 3.25% of its assets in 3.47M PMV Pharmaceuticals shares, valued at 5.23M$.

Who is the top mutual fund holder of PMV Pharmaceuticals shares?

Vanguard Total Stock Mkt Idx Inv is the top mutual fund holder of PMV Pharmaceuticals shares, with 2.95% of its total shares outstanding invested in 1.52M PMV Pharmaceuticals shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools